We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI-Based Test Speeds Multiple Sclerosis Diagnosis and Reduces Lumbar Punctures

By HospiMedica International staff writers
Posted on 28 Sep 2026

Multiple sclerosis (MS) is a neurological condition marked by multiple scars in the brain or spine. More...

Diagnosis can be difficult because symptoms vary and the disease can progress at different rates. Many patients suspected of having MS have undergone lumbar puncture after standard MRI, a procedure that can cause headaches, back pain, and unintended complications. Researchers have now introduced an MRI-based test that aims to make diagnosis faster and less invasive.

The University of Nottingham team developed the test using a T2*-weighted MRI scan on a clinical MRI scanner of the type used in neuroscience centers. The scan adds about six minutes to the imaging session and allows clinicians to view MS lesions in greater detail. It specifically helps doctors identify whether small veins run through the middle of lesions, a finding known as the central vein sign.

The central vein sign is clinically useful because MS lesions form around small veins. Other conditions do not form around veins in the same way, which allows the sign to help distinguish MS from alternative diagnoses. The Nottingham team has incorporated the method into the National Health Service diagnostic process for MS, with scans scheduled before first clinic appointments to improve service efficiency.

During rollout at an NHS trust in England, the average time to diagnosis was 2.9 months with the new process. This compared with 5.6 months in the usual outpatient pathway, reducing the diagnostic wait by an average of 83 days. The team also estimated cost savings of about GBP 292 per patient in Nottingham, while noting that the estimate may understate savings for hospitals that perform more lumbar punctures.

The findings were published in Neurology: Clinical Practice. The test is now in use in Nottingham and is being adopted in other neurology departments worldwide. The team has also encouraged other hospitals across the UK to begin using the MRI-based approach.

“Spotting the central vein sign completely changes the MS diagnostic journey. By viewing lesions in far greater clarity, we can make an accurate diagnosis without invasive lumbar punctures—reducing unnecessary delays so people can start getting answers sooner,” said Dr. Christopher Gilmartin, the project's first author.

Related Links
University of Nottingham 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Patient Monitoring System
AlarmSense
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.